What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Posted inAlzheimer's Assn Alzheimer's Disease Amgen Inc Banner Alzheimer's Institute Biogen Inc Brain Clinical Trials Drugs (Pharmaceuticals) Eisai Co Ltd Elderly Eli Lilly and Company Food and Drug Administration Genetics and Heredity Government Accountability Office Hemorrhagic Stroke Institute for Clinical and Economic Review Kisunla Leqembi (Drug) Medicine and Health Novartis AG Retirement Communities and Assisted Living United States Villages, The (Fla)

What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.
U.S. Unveils Price Limits for 10 Costly or Common Medications
Posted inAbbVie Inc Amgen Inc AstraZeneca PLC Biden, Joseph R Jr Boehringer Ingelheim GmbH Bristol Myers Squibb Company Drugs (Pharmaceuticals) Eli Lilly and Company Harris, Kamala D Inflation Reduction Act of 2022 Johnson & Johnson Medicare Merck & Company Inc Novartis AG Novo Nordisk A/S Pfizer Inc Presidential Election of 2024 Trump, Donald J United States Politics and Government

U.S. Unveils Price Limits for 10 Costly or Common Medications

The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations
Posted inAbbVie Inc Amgen Inc AstraZeneca PLC Biden, Joseph R Jr Boehringer Ingelheim GmbH Bristol Myers Squibb Company Drugs (Pharmaceuticals) Eli Lilly and Company Harris, Kamala D Inflation Reduction Act of 2022 Johnson & Johnson Medicare Merck & Company Inc Novartis AG Novo Nordisk A/S Pfizer Inc Presidential Election of 2024 Trump, Donald J United States Politics and Government

U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations

The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
A Dilemma for Governments: How to Pay for Million-Dollar Therapies
Posted inBrazil Children and Childhood Disabilities Drugs (Pharmaceuticals) Genetic Engineering Genetics and Heredity Medicine and Health Novartis AG Spinal Muscular Atrophy Suits and Litigation (Civil)

A Dilemma for Governments: How to Pay for Million-Dollar Therapies

A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.